Grand Brilliance Group Holdings Limited provided consolidated earnings guidance for the year ended March 31, 2022. For the period, the Group is expected to record a consolidated profit attributable to the owners of the Company of approximately HKD 3.8 million to HKD 4.2 million for the year ended 31 March 2022. It decreased when compared with the consolidated profit attributable to the owners of the Company of HKD 7.9 million for the year ended 31 March 2021, primarily attributable to increase of workforce and related staff costs during the year; and an one-off employment support scheme government grant in last year.
Grand Brilliance Group Holdings Limited
Equities
8372
KYG4136R1020
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.105 HKD | -4.55% | +3.96% | +5.00% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.00% | 11.26M | |
-3.41% | 9.39B | |
+2.16% | 1.45B | |
-2.91% | 1.43B | |
-5.80% | 1.21B | |
-16.56% | 899M | |
+2.34% | 480M | |
+2.71% | 440M | |
-47.72% | 369M | |
-21.86% | 356M |
- Stock Market
- Equities
- 8372 Stock
- News Grand Brilliance Group Holdings Limited
- Grand Brilliance Group Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended March 31, 2022